Prestige Raises OTC Brand Acquisition Sights
This article was originally published in The Pink Sheet Daily
CEO Matthew Mannelly says the firm currently could spend $1 billion in acquisitions and could target larger brands than it has acquired so far. “Maybe a $10 million or $15 million brand doesn't move the needle for us as much anymore as it did,” he says.
You may also be interested in...
Five firms' “representations create a false impression that [their] products have been authorized for emergency use by FDA and are misleading," states FDA's medical device center.
Worldwide consumer health sales in January-March period were down 3.3% to $3.5bn with results off 7.4% to $1.6bn in the US and up 0.5% to $1.9bn internationally. However, excluding “COVID-19 comparison” in the year-ago period, the consumer health segment grew low-single-digits.
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.